SEC Form 4 · accession 0000882796-26-000061
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Milano
Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2026 | A | 1,159 | $9.70 | A | 109,642 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Chair retainer of $22,500.